Workflow
CVS Health(CVS)
icon
Search documents
Health Insurers Now Get a Pulse: 3 Stocks to Jump in 2026
ZACKS· 2025-12-17 15:10
Key Takeaways Managed care stocks were pressured by high utilization, but pricing and cost trends are now stabilizing.UNH benefits from scale and Optum integration as margins normalize after earlier medical cost pressure.CVS and CNC show improving execution as pricing discipline and enrollment trends support 2026 earnings.The overall healthcare sector entered 2025 on shaky ground. Managed care stocks, especially HMOs, were weighed down by stubbornly high medical utilization, tighter reimbursement assumption ...
Codoxo's Oversubscribed Series C Led by CVS Health Ventures to Revolutionize Payment Integrity for America's Largest Health Plans
Businesswire· 2025-12-17 14:15
DULUTH, Ga.--(BUSINESS WIRE)--Codoxo, the leading provider of AI and generative AI-powered healthcare payment integrity solutions, raised $35M in Series C funding, led by CVS Health Ventures. Echo Health Ventures joins the round as a new investor, with continued investment from existing investors including Sands Capital, 111 West Capital, Brewer Lane Ventures, Wipro Ventures, 450 Ventures (venture arm of Blue Cross and Blue Shield of Alabama) and QED Investors. This milestone brings Codoxo's to. ...
Final Trade: ETH, GM, CVS, NFLX
Youtube· 2025-12-16 23:21
Core Viewpoint - The discussion highlights the volatility in the cryptocurrency market, particularly Ethereum, and suggests a cautious approach to investing while also considering profit-taking strategies in traditional stocks like General Motors and CVS [1]. Group 1: Cryptocurrency Insights - There is a warning about the risks of trying to time the market by picking bottoms in Ethereum, indicating that this strategy can lead to significant losses [1]. - The mention of adding to Ethereum holdings suggests a belief in its long-term potential despite short-term volatility [1]. Group 2: Stock Market Strategies - The conversation includes advice on taking profits from long positions in General Motors, indicating a strategy of capitalizing on gains [1]. - CVS is identified as a potential candidate for a bullish reversal, suggesting optimism about its future performance [1]. - There is a belief that Netflix may experience a bounce, indicating a positive outlook for the company in the near term [1].
CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents
ZACKS· 2025-12-15 15:16
Key Takeaways CVS began offering MMR vaccines in South Carolina, and the stock rose 2.4% following the announcement. CVS Health's Pharmacy and Consumer Wellness unit runs 9,000 sites and posted 12% revenue growth in Q3 2025. CVS' Aetna is rolling out a generative AI chat experience to help members navigate benefits more easily.CVS Health (CVS) has recently announced the offering of measles-mumps-rubella (MMR) vaccine to residents post the current outbreak in South Carolina. Both CVS Pharmacy stores and Minu ...
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Bristol-Myers Squibb (NYSE:BMY), CVS Health (NYSE:CVS)
Benzinga· 2025-12-15 11:46
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.Below are the ratings of the most accurate analysts for three high-yield ...
Top Wall Street analysts are upbeat on these 3 dividend stocks for enhanced returns
CNBC· 2025-12-14 12:56
Core Insights - The U.S. Federal Reserve has cut key interest rates by 25 basis points for the third time in 2025, which may lead investors to consider dividend stocks for stable income and enhanced returns [1] Group 1: Dividend Stocks Overview - Top Wall Street analysts have identified attractive dividend-paying stocks, which can assist investors in making informed decisions [2] Group 2: Devon Energy - Devon Energy (DVN) returned $401 million to shareholders in Q3 2025 through share repurchases and dividends, with a fixed quarterly dividend of $0.24 per share, yielding 2.5% [3] - JP Morgan analyst Arun Jayaram upgraded DVN to buy from hold, lowering the price target to $44 from $49, citing compelling valuation and free cash flow gains from a $1 billion optimization plan [4][5] - Devon achieved approximately 60% of its $1 billion optimization goal within six months, and Jayaram expects stable well productivity in 2026 and 2027 [5][6] - Jayaram is optimistic about Devon's acreage position in key regions and its potential for lower-risk, high-return drilling opportunities [7] Group 3: EOG Resources - EOG Resources (EOG) paid $545 million in dividends and repurchased $440 million in shares in Q3 2025, with a quarterly dividend of $1.02 per share, yielding 3.7% [9] - Siebert Williams Shank analyst Gabriele Sorbara reaffirmed a buy rating on EOG with a price target of $150, highlighting its ability to navigate commodity cycles and strong free cash flow generation [11] - EOG is committed to returning at least 70% of its free cash flow to shareholders, with the potential to return 100% based on its balance sheet strength [12] - The company is leveraging advanced technology to identify multiple development targets in the Delaware Basin and is ahead of its synergy targets from the Encino acquisition [13] Group 4: CVS Health - CVS Health (CVS) is undergoing a turnaround, expecting a mid-teens adjusted EPS CAGR through 2028, with a quarterly dividend of $0.665 per share, yielding 3.4% [15] - Mizuho analyst Ann Hynes reiterated a buy rating on CVS, raising the price target to $95, citing structural improvements in retail earnings [16] - CVS' mid-teens adjusted EPS CAGR target does not include potential share buybacks, which may occur once leverage targets are met [17] - The company anticipates a decline in the medical loss ratio by about 50 basis points in 2026, driven by better pricing and strategic exits from certain business segments [18] - CVS expects flat adjusted operating income growth in its Pharmacy and Consumer Wellness segment, improved by market share gains and cost savings [19]
The consumer is frustrated right now, says CVS Health CEO David Joyner
Youtube· 2025-12-11 21:04
But what's happening with this turnaround CBS Health. This stock has become the best performer in the healthc care sector under CEO David Joiner and shot up another 2% today as management laid out some bullish long-term earnings targets. Earlier today, we welcome David Joiner, the president CEO of CVS Health to find out more.Check it out. David, some people come on, they got a narrative. They tell you some story and you get excited and then it doesn't doesn't happen.You I believe are actually transforming t ...
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak
Prnewswire· 2025-12-11 16:30
Unvaccinated residents can receive a measles vaccine at select CVS Pharmacy and MinuteClinic locations across the state WOONSOCKET, R.I., Dec. 11, 2025 /PRNewswire/ -- As South Carolina public health officials work to stop the spread of measles following the current outbreak in the state, CVS Health® (NYSE:CVS) is offering the measles-mumps-rubella (MMR) vaccine to residents. Both CVS Pharmacy® stores and MinuteClinic® walk-in medical clinics in the area have vaccines available to help protect patients agai ...
Jim Cramer on CVS: “This Stock Has Become the Best Performer in the Healthcare Sector”
Yahoo Finance· 2025-12-11 12:56
CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently commented on. Cramer praised the company’s CEO during the episode, as he commented: “This stock has become the best performer in the healthcare sector under CEO David Joyner and shot up another 2% today as management laid out some bullish long-term earnings targets.” Stock market data showing an upward trajectory. Photo by Burak The Weekender on Pexels CVS Health Corporation (NYSE:CVS) provides healthcare solutions through insu ...
Truist上调西维斯健康目标价至98美元
Ge Long Hui· 2025-12-11 03:04
Truist Securities将西维斯健康的目标价从95美元上调至98美元,维持"买入"评级。(格隆汇) ...